2-Chloro-4-(4-chloro-phenyl)-6-methyl-pyrimidine → 2-(4-Bromo-imidazol-1-yl)-4-(4-chloro-phenyl)-6-methyl-pyrimidine
반응식
Cl[C:2]1[N:7]=[C:6]([C:8]2[CH:13]=[CH:12][C:11]([Cl:14])=[CH:10][CH:9]=2)[CH:5]=[C:4]([CH3:15])[N:3]=1.[Br:16][C:17]1[N:18]=[CH:19][NH:20][CH:21]=1>>[Br:16][C:17]1[N:18]=[CH:19][N:20]([C:2]2[N:7]=[C:6]([C:8]3[CH:13]=[CH:12][C:11]([Cl:14])=[CH:10][CH:9]=3)[CH:5]=[C:4]([CH3:15])[N:3]=2)[CH:21]=1참가 물질
3
실험 절차
The title compound was prepared from 2-chloro-4-(4-chloro-phenyl)-6-methyl-pyrimidine (example A.11) (1.91 g, 8.0 mmol) and commercially available 4-bromo-imidazole (1.76 g, 12.0 mmol) according to the general procedure IVa. Obtained as a light brown solid (2.76 g, 98%). MS (ISP) 349.1 [(M+H)+]; mp 176-178° C.
출처 및 근거
- ORD 기록
- ord-ca66fb0132a140099f49f71a3aa65366
- 출처 데이터셋
- uspto-grants-2012_05
- 특허 번호
- US08183262B2
반응 노트
불러오는 중…